Kiromic BioPharma, Inc. is a cutting-edge biotechnology company based in Lubbock, TX, dedicated to revolutionizing cancer treatment through innovative car-t therapy. With a focus on immunotherapy drugs, Kiromic aims to address the 70% of cancer deaths in the US that could potentially be treatable with their groundbreaking approach.
Through their advanced technology pipeline and state-of-the-art facilities, Kiromic BioPharma is committed to providing hope to patients by offering a more effective and targeted treatment option for cancer. With a strong leadership team and scientific advisory board, the company is at the forefront of developing solutions to improve patient outcomes and minimize harmful side effects.
Generated from the website